Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cleveland BioLabs stock | $3.56

Learn how to easily invest in Cleveland BioLabs stock.

Cleveland BioLabs Inc is a biotechnology business based in the US. Cleveland BioLabs shares (CBLI) are listed on the NASDAQ and all prices are listed in US Dollars. Cleveland BioLabs employs 18 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Cleveland BioLabs

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CBLI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cleveland BioLabs stock price (NASDAQ: CBLI)

Use our graph to track the performance of CBLI stocks over time.

Cleveland BioLabs shares at a glance

Information last updated 2021-10-16.
Latest market close$3.56
52-week range$2.11 - $9.53
50-day moving average $3.62
200-day moving average $3.62
Wall St. target price$2.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.74

Buy Cleveland BioLabs shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cleveland BioLabs stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cleveland BioLabs price performance over time

Historical closes compared with the close of $3.56 from 2021-10-22

1 week (2021-10-15) 10.56%
1 month (2021-09-23) 30.88%
3 months (2021-07-23) -22.27%
6 months (2021-04-23) -31.80%
1 year (2020-10-23) 36.92%
2 years (2019-10-23) 352.41%
3 years (2018-10-23) 122.50%
5 years (2016-10-21) 128.21%

Cleveland BioLabs financials

Revenue TTM $106,900
Gross profit TTM $-428,128
Return on assets TTM -20.33%
Return on equity TTM -31.86%
Profit margin 0%
Book value $0.60
Market capitalisation $107.7 million

TTM: trailing 12 months

Shorting Cleveland BioLabs shares

There are currently 15,617 Cleveland BioLabs shares held short by investors – that's known as Cleveland BioLabs's "short interest". This figure is 76.1% down from 65,413 last month.

There are a few different ways that this level of interest in shorting Cleveland BioLabs shares can be evaluated.

Cleveland BioLabs's "short interest ratio" (SIR)

Cleveland BioLabs's "short interest ratio" (SIR) is the quantity of Cleveland BioLabs shares currently shorted divided by the average quantity of Cleveland BioLabs shares traded daily (recently around 195212.5). Cleveland BioLabs's SIR currently stands at 0.08. In other words for every 100,000 Cleveland BioLabs shares traded daily on the market, roughly 80 shares are currently held short.

However Cleveland BioLabs's short interest can also be evaluated against the total number of Cleveland BioLabs shares, or, against the total number of tradable Cleveland BioLabs shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cleveland BioLabs's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Cleveland BioLabs shares in existence, roughly 0 shares are currently held short) or 0.0008% of the tradable shares (for every 100,000 tradable Cleveland BioLabs shares, roughly 1 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cleveland BioLabs.

Find out more about how you can short Cleveland BioLabs stock.

Cleveland BioLabs share dividends

We're not expecting Cleveland BioLabs to pay a dividend over the next 12 months.

Have Cleveland BioLabs's shares ever split?

Cleveland BioLabs's shares were split on a 1:20 basis on 27 January 2015. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cleveland BioLabs shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Cleveland BioLabs shares which in turn could have impacted Cleveland BioLabs's share price.

Cleveland BioLabs share price volatility

Over the last 12 months, Cleveland BioLabs's shares have ranged in value from as little as $2.11 up to $9.53. A popular way to gauge a stock's volatility is its "beta".

CBLI.US volatility(beta: 0.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cleveland BioLabs's is 0.6837. This would suggest that Cleveland BioLabs's shares are less volatile than average (for this exchange).

Cleveland BioLabs overview

Cytocom, Inc. , a clinical-stage biopharmaceutical company, develops novel small molecule immunotherapies targeting cancer, autoimmune, inflammatory, and infectious diseases. Its platform, Advanced Immunomodulating Multi-receptor System (AIMS), offers noroxymorphone analogs multi-receptor modulating therapies and proenkephalin analogs multi-receptor modulating therapies. The company also has various clinical-stage development programs, including CYTO-200 for Crohn's disease, fibromyalgia, multiple sclerosis, and covid-19; CYTO-400 for hepatocellular and pancreatic cancer; and CYTO-600 for acute radiation syndrome, advanced solid tumors, and vaccine adjuvant. Cytocom, Inc. has a collaboration agreement with the La Jolla Institute for Immunology for research and development of new immune-modulating agents targeting toll-like receptors for the treatment of cancer, infectious, autoimmune, and chronic inflammatory diseases. The company is based in Fort Collins, Colorado.

Cleveland BioLabs in the news

There are no recent company news

Frequently asked questions

What percentage of Cleveland BioLabs is owned by insiders or institutions?
Currently 52.548% of Cleveland BioLabs shares are held by insiders and 4.774% by institutions.
How many people work for Cleveland BioLabs?
Latest data suggests 18 work at Cleveland BioLabs.
When does the fiscal year end for Cleveland BioLabs?
Cleveland BioLabs's fiscal year ends in December.
Where is Cleveland BioLabs based?
Cleveland BioLabs's address is: 2537 Research Boulevard, Fort Collins, CO, United States, 80526
What is Cleveland BioLabs's ISIN number?
Cleveland BioLabs's international securities identification number is: US23284M1009
What is Cleveland BioLabs's CUSIP number?
Cleveland BioLabs's Committee on Uniform Securities Identification Procedures number is: 185860103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site